Ian Karp | Senior Vice President, Investor and Public Relations |
Richard Paulson | President and Chief Executive Officer |
Michael Kauffman | Co-Founder, Senior Clinical Advisor and Board Member |
Michael Mason | Chief Financial Officer |
John Demaree | Chief Commercial Officer |
Stephen Mitchener | Chief Business Officer |
Brian Abrahams | RBC Capital Markets |
Maury Raycroft | Jefferies |
Peter Lawson | Barclays |
Eric Joseph | JPMorgan |
David Lebowitz | Morgan Stanley |
Jonathan Chang | SVB Leerink |
Ed White | H.C. Wainwright |
Colleen Kusy | Baird |
Arlinda Lee | Canaccord |
Good morning. My name is Jason, and I will be your conference operator for today. At this time, I’d like to welcome everyone to Karyopharm Therapeutics' First Quarter 2021 Financial Results Conference Call. There will be a question-and-answer session to follow. Please be advice that this call is being recorded at the company's request.